For example, comparative metabolomic analyses of IDH1-mutant gliomas revealed a significant increase in intracellular isocitrate levels, reflecting impaired oxidative decarboxylation of isocitrate to α-ketoglutarate and a shift in metabolic fluxes [34]. This evidence concerns the gene IDH1 and central nervous system cancer.